The historic rise of Viagra has long been a example of pharmaceutical success, yet its position within the broader market now triggers questions about future yields . Generic versions are diminishing patent protection , prompting concerns that betting on companies significantly dependent to Viagra's once-dominant influence could be a dangerous stra